AR107984A1 - Compuestos de pirrolotriazina como inhibidores de tam - Google Patents

Compuestos de pirrolotriazina como inhibidores de tam

Info

Publication number
AR107984A1
AR107984A1 ARP170100750A ARP170100750A AR107984A1 AR 107984 A1 AR107984 A1 AR 107984A1 AR P170100750 A ARP170100750 A AR P170100750A AR P170100750 A ARP170100750 A AR P170100750A AR 107984 A1 AR107984 A1 AR 107984A1
Authority
AR
Argentina
Prior art keywords
alkyl
independently selected
alkylene
cycloalkyl
membered heterocycloalkyl
Prior art date
Application number
ARP170100750A
Other languages
English (en)
Spanish (es)
Inventor
Jincong Zhuo
Song Mei
Taisheng Huang
Chunhong He
Joseph Glenn
Hao Feng
David M Burns
Joseph Barbosa
xiaozhao Wang
Yun-Long Li
Original Assignee
Incyte Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Incyte Corp filed Critical Incyte Corp
Publication of AR107984A1 publication Critical patent/AR107984A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/53Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ARP170100750A 2016-03-28 2017-03-27 Compuestos de pirrolotriazina como inhibidores de tam AR107984A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201662314066P 2016-03-28 2016-03-28

Publications (1)

Publication Number Publication Date
AR107984A1 true AR107984A1 (es) 2018-07-04

Family

ID=63036861

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP170100750A AR107984A1 (es) 2016-03-28 2017-03-27 Compuestos de pirrolotriazina como inhibidores de tam

Country Status (2)

Country Link
AR (1) AR107984A1 (fr)
MA (1) MA44503B1 (fr)

Also Published As

Publication number Publication date
MA44503A (fr) 2019-02-06
MA44503B1 (fr) 2023-11-30

Similar Documents

Publication Publication Date Title
AR109595A1 (es) Compuestos de pirazolopirimidina y usos de estos como inhibidores de hpk1
AR087591A1 (es) Derivados de ciclohexil azetidina como inhibidores de jak
AR109596A1 (es) Compuestos pirazolopiridina y sus usos
AR106756A1 (es) Compuestos y composiciones útiles para el tratamiento de trastornos relacionados con ntrk
AR099379A1 (es) Compuestos tricíclicos como agentes antineoplásicos
AR102171A1 (es) Compuestos sustituidos de aminopurina, sus composiciones y su uso en el tratamiento o prevención de melanoma
AR107293A1 (es) COMPUESTOS DE PIRIDINA Y PIRIDIMINA COMO INHIBIDORES DE PI3K-g
CO2019005824A2 (es) Ácidos propiónicos 3-sustituidos como inhibidores de la integrina alfa v
CO7160015A2 (es) Benzamidas n-sustituidas y su uso en el tratamiento del dolor
AR095426A1 (es) Inhibidores tripeptídicos de la epoxicetona proteasa
CR20160523A (es) Compuestos de imidazo[4,5-c]quinolin-2-ona y su uso para tratar cáncer
AR083849A1 (es) Antagonistas de mdm2 de espiro-oxindol
AR107928A1 (es) Moduladores alostéricos de receptores de acetilcolina nicotínicos
SV2018005663A (es) Compuestos de imidazo [4,5-c] quinolin-2-ona y su uso en el tratamiento del cancer
AR100154A1 (es) Compuesto heterocíclico que contiene nitrógeno
AR089776A1 (es) 5,8-dihidro-6h-pirazolo[3,4-h]quinazolinas como inhibidores de igf-1r/ir
AR079226A1 (es) Espiroindolinona- pirrolidinas, procesos de preparacion y uso de los mismos para el tratamiento y profilaxis del cancer
AR098432A1 (es) Compuestos heterocíclicos
AR098776A1 (es) Derivados del isocromeno como inhibidores de las fosfoinositido-3 quinasas
AR105893A1 (es) Derivados del anillo (hetero) aromático sustituidos con carboxi como inhibidores de xantina oxidasa y del transportador 1 del anión urato
ECSP11010901A (es) Compuestos de amida útiles en terapia
AR096721A1 (es) Compuestos de tetrahidrocarbazol y carbazol carboxamida sustituidos
CL2019001041A1 (es) Compuestos terapéuticos y métodos para utilizarlos.
AR101964A1 (es) Compuestos de imidazopiridazina como moduladores de pi3k
AR107054A1 (es) DERIVADOS DE ISOINDOL Y COMPOSICIONES FARMACÉUTICAS QUE LOS COMPRENDEN PARA EL TRATAMIENTO DE ENFERMEDADES MEDIADAS POR RORg Y RORgt

Legal Events

Date Code Title Description
FG Grant, registration
FG Grant, registration